LYTIR

Company · LTGO

Latigo Biotherapeutics, Inc.

Nasdaq's symbol directory lists LTGO on Nasdaq as “Latigo Biotherapeutics, Inc. - Common Stock”.

In the 12 months to Nov 19, 2026: insiders bought on 1 occasion ($2.5M); 8 filings by holders of 5% or more; 1 company report (Form 8-K, since May 26, 2026).

All insider filings at the SEC

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Tananbaum James B. bought on 1 day latest Aug 10, 2026 bought $2.5M
Every trade (1)
  1. BUYTananbaum James B. bought Aug 10, 2026 140,000 shares filing $2.5M

Large holders · SEC Schedules 13D and 13G

Five percent and over

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G

  1. 5AM Ventures VI, L.P. filed Nov 16, 2026 Schedule 13G passive filing 11%
  2. Blue Owl Capital Holdings LP filed Nov 13, 2026 Schedule 13G passive filing 5.43%
  3. AI Biotechnology LLC filed Nov 6, 2026 Schedule 13G/A passive filing 4.8%
  4. Westlake BioPartners Fund I, L.P. filed Oct 29, 2026 Schedule 13G passive filing 19.9%
  5. AI Biotechnology LLC filed Aug 18, 2026 Schedule 13G passive filing 5%
  6. RA CAPITAL MANAGEMENT, L.P. filed Aug 17, 2026 Schedule 13G passive filing 8.4%
  7. Foresite Capital Fund VI LP filed Aug 17, 2026 Schedule 13D may seek influence 2,203,800 shares filing 3.5%
  8. Deep Track Capital, LP filed Aug 13, 2026 Schedule 13G passive 4,445,656 shares filing 7.03%

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Results of operations and financial condition; Departure or appointment of directors or officers filing Nov 5, 2026

Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.